|
| 37768647 | Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes. | J Crohns Colitis | 2024 |
| 37721310 | Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study. | Am J Gastroenterol | 2024 |
| 37291531 | Epidemiology, validation, and clinical characteristics of inflammatory bowel disease: the ABIS birth cohort study. | | 2023 |
| 35459973 | Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease. | Dig Dis Sci | 2023 |
| 36029471 | Analysis of Systemic Epigenetic Alterations in Inflammatory Bowel Disease: Defining Geographical, Genetic and Immune-Inflammatory influences on the Circulating Methylome. | J Crohns Colitis | 2023 |
| 36219554 | Mucosal and Plasma Metabolomes in New-onset Paediatric Inflammatory Bowel Disease: Correlations with Disease Characteristics and Plasma Inflammation Protein Markers. | | 2023 |
| 36152897 | I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease. | Clinical Gastroenterology and Hepatology | 2023 |
| 35776552 | The Risk of Serious Infections Before and After Anti-TNF Therapy in Inflammatory Bowel Disease: A Retrospective Cohort Study. | Inflamm Bowel Dis | 2023 |
| 37856566 | Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. | PLoS Med | 2023 |
| 37662517 | Statin use and risk of colorectal cancer in patients with inflammatory bowel disease. | EClinicalMedicine | 2023 |
| 37594381 | Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden. | Aliment Pharmacol Ther | 2023 |
| 37834994 | Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus. | | 2023 |
| 37586038 | Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations. | | 2023 |
| 37882356 | Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels. | | 2023 |
| 38058270 | Eosinophilic esophagitis is associated with increased risk of later inflammatory bowel disease in a nationwide Swedish population cohort. | | 2023 |
| 37274297 | Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study. | | 2023 |
| 36576886 | Bidirectional Mendelian Randomisation Analysis Provides Evidence for the Causal Involvement of Dysregulation of CXCL9, CCL11 and CASP8 in the Pathogenesis of Ulcerative Colitis. | | 2023 |
| 36821532 | Long-term risk of inflammatory bowel disease after endoscopic biopsy with normal mucosa: A population-based, sibling-controlled cohort study in Sweden. | PLoS Med | 2023 |
| 36760205 | Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden. | Int J Cancer | 2023 |
| 37256716 | Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease. | | 2023 |
| 37316347 | Long-term Risk of Stroke in Patients With Inflammatory Bowel Disease: A Population-Based, Sibling-Controlled Cohort Study, 1969-2019. | Neurology | 2023 |
| 36694402 | Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease. | | 2023 |
| 36994851 | Inflammatory Bowel Disease and Risk of Colorectal Polyps: A Nationwide Population-Based Cohort Study From Sweden. | J Crohns Colitis | 2023 |
| 36937140 | The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. | Crohns Colitis 360 | 2023 |
| 36929241 | Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease. | Dig Dis Sci | 2023 |
| 36788016 | Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis. | Gut | 2023 |
| 34693837 | Mortality in patients with Crohn's disease in ÿrebro, Sweden 1963-2010. | Scandinavian Journal of Gastroenterology | 2022 |
| 35460098 | Age determines the risk of familial inflammatory bowel disease-A nationwide study. | Aliment Pharmacol Ther | 2022 |
| 35964121 | Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study. | BMC Cancer | 2022 |
| 35903063 | Normal Gastrointestinal Mucosa at Biopsy and Overall Mortality: Nationwide Population-Based Cohort Study. | Clin Epidemiol | 2022 |
| 35512691 | Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden. | J Crohns Colitis | 2022 |
| 35834389 | Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register. | United European Gastroenterol J | 2022 |
| 35613563 | Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. | Am J Gastroenterol | 2022 |
| 35928254 | Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis. | Clinical and Experimental Gastroenterology | 2022 |
| 36125530 | Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017. | J Pediatr Gastroenterol Nutr | 2022 |
| 35916190 | Colorectal cancer in elderly-onset inflammatory bowel disease: a 1969-2017 Scandinavian register-based cohort study. | Aliment Pharmacol Ther | 2022 |
| 36467453 | Histological remission in inflammatory bowel disease and risk of adverse pregnancy outcomes: A nationwide study. | EClinicalMedicine | 2022 |
| 34618020 | Probability of Stoma in Incident Patients With Crohn's Disease in Sweden 2003-2019: A Population-based Study. | Inflamm Bowel Dis | 2022 |
| 34907544 | A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. | Aliment Pharmacol Ther | 2022 |
| 34850856 | Prognostic Biosignatures at Ileocecal Resection: Hope or Reality? | | 2022 |
| 35212366 | Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. | | 2022 |
| 35189386 | IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. | Clin Gastroenterol Hepatol | 2022 |
| 35022690 | Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease. | J Crohns Colitis | 2022 |
| 35185343 | Mucosal Gene Transcript Signatures in Treatment Naïve Inflammatory Bowel Disease: A Comparative Analysis of Disease to Symptomatic and Healthy Controls in the European IBD-Character Cohort. | Clinical and Experimental Gastroenterology | 2022 |
| 34415803 | Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. | Scandinavian Journal of Gastroenterology | 2021 |
| 32474410 | Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden. | Gut | 2021 |
| 33704918 | Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden. | United European Gastroenterol J | 2021 |
| 33640971 | Association Between Inflammatory Bowel Disease and Psychiatric Morbidity and Suicide: A Swedish Nationwide Population-Based Cohort Study With Sibling Comparisons. | J Crohns Colitis | 2021 |
| 34286871 | Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register. | Aliment Pharmacol Ther | 2021 |
| 33632044 | Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register - a validation study. | Scand J Gastroenterol | 2021 |